Ys. Chen et al., LOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS TO CELLS OF VASCULAR AND AVASCULAR EPIRETINAL MEMBRANES, British journal of ophthalmology, 81(10), 1997, pp. 919-926
Aims/background-Epiretinal membranes (ERMs) arise from a variety of ca
uses or, in some cases, for unknown reasons. Once established, ERMs te
nd to progress, becoming more extensive and exerting increasing tracti
on along the inner surface of the retina. One possible cause for their
progression is the production of growth factors by cells within ERMs
that may provide autocrine or paracrine stimulation. Platelet derived
growth factor (PDGF) and its receptors have been localised to cells of
ERMs and may play such a role. In this study, comparative data were s
ought for several other growth factors that have been implicated in ER
M formation. Methods-Immunohistochemical staining of ERMs was done for
PDGF-A, PDGF-B, basic fibroblast growth factor (bFGF), three isoforms
of transforming growth factor beta (TGF-beta), and vascular endotheli
al growth factor (VEGF) and its receptors, flt-1 and flk-1/KDR. Expres
sion of flt-1 and flk-1/KDR was examined in cultured retinal pigmented
epithelial (RPE) cells and retinal glia from postmortem eyes by immun
ohistochemistry and by reverse transcription coupled to polymerase cha
in reaction (RT-PCR). Results-Staining was most intense and most frequ
ently observed for VEGF and PDGF-A, both in vascular and avascular ERM
s. The majority of cells stained for VEGF in nine of 11 (81.8%) diabet
ic ERMs and in 14 of 24 (58.3%) proliferative vitreoretinopathy ERMs.
The receptors for VEGF, flt-1, and flk-1/KDR were also identified on c
ells in ERMs and on cultured RPE cells. By RT-PCR, mRNA for flt-1 was
identified in RPE cells and retinal glia, and mRNA for flk-1/KDR was i
dentified in RPE cells. Conclusions-These data show that VEGF and its
receptors are localised to both vascular and avascular ERMs and sugges
t that VEGF, like PDGF-A, may be an autocrine and paracrine stimulator
that may contribute to progression of vascular and avascular ERMs.